Objective: To present a case of a benign orbito-maxillary tumor behaving as an invasive, expansive malignancy.
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A trial of oral Prednisone at 0.2 mg/kg/day or 4 mg daily for 1 month apparently decreased the size of the mass. The dose was then tapered to 2 mg once a day then 1 mg daily for 2 weeks each but the mass increased in size again. After 2 months of steroid therapy, an orbital computed tomography (CT) scan revealed a 3.6 x 2.7 x 2.7 cm mass within the right orbit and maxillary sinus ( Figure 4 ) slightly larger than previously seen on MRI. Orbital floor lysis, as well as the superior displacement and proptosis of the right globe, were still evident.
The patient was referred to our institution for further management. He presented with a 2 x 2 cm mass over the right lower eyelid and slight proptosis of the right eyeball with unremarkable visual acuity, extraocular muscle (EOM) motility, and fundoscopic exam. An incision biopsy via Caldwell-luc approach revealed "small round cell tumor, consider olfactory neuroblastoma" ( Figure 5 ).
Special staining was negative for Chromogranin and LCA (leukocyte common antigen) but NSE (neuron-specific enolase) was positive, consistent with olfactory neuroblastoma. A positive NSE does not confirm the diagnosis nor does a negative chromogranin and LCA rule it out because it is not unusual for this kind of tumor to stain only focally. A repeat biopsy was again recommended by the pathologist. We requested a CT scan of the paranasal sinuses ( Figure 6 ), which did not show interval changes from previous CT and MRI studies.
Closer examination of all radiologic studies revealed an unremarkable olfactory cleft with no sign of sinus wall bowing characteristic of an olfactory neuroblastoma. Clinically, the mass had not increased in size though 6 months had passed since the first biopsy. Doubting the diagnosis of olfactory neuroblastoma for lack of clinical and radiologic corroboration, another biopsy was done. The histopathologic reading of "chronic and acute inflammation negative for malignancy" (Figure 7 ) was not compatible with the bony lysis seen on CT and MRI.
We decided to debulk the tumor for both diagnostic and therapeutic purposes. The specimen was signed out as "Inflammatory Pseudotumor, right infraorbital area" (Figure 8 ).
The patient was given oral Prednisone at 2 mg/kg /day or 40 mg daily for 2 weeks, 32 mg once a day for 2 weeks, 24 mg once a day for 2 weeks and 24 mg daily for 4 weeks. 5 months post-surgery, the patient remained asymptomatic with no sign of recurrence of the mass (Figure 9 ). A repeat CT scan of the paranasal sinus revealed significant regression of the previously noted inferior orbital soft tissue mass (1 x 0.4 cm) ( Figure 10 
DISCUSSION
Orbital mass lesions may arise primarily within the orbit, extend from contiguous structures, or be metastatic from a distant primary malignancy. Primary orbital masses include congenital, vascular, neural, and mesenchymal tumors. Other types of lesions masquerading as true neoplasms include lymphoproliferative disorders, autoimmune diseases, and infectious processes. Congenital lesions include dermoid cysts, hamartomas and teratomas. The following table (Table 1) shows the most common pediatric tumors which present in the orbital area.
An olfactory neuroblastoma was considered in our second biopsy but CT and MRI studies of our patient did not support this diagnosis. Olfactory neuroblastoma (Esthesioneuroblastoma) displays a variety of imaging characteristics and aggressiveness, characterized by bowing of the sinus walls, usually replacing the turbinates, septum, and sinus walls with extension into contiguous areas 12 . Not only did CT and MRI studies of our patient not show any of these findings, the unremarkable olfactory cleft cast more doubt on this diagnosis.
The acute and chronic inflammation seen on the third biopsy was possible following initial response to steroids but does not explain the lysis or bone destruction evident in the CT and MRI studies. The great discrepancy between malignancy and mere inflammation prompted tumor debulking to obtain a larger specimen and once and for all, put this diagnostic dilemma to rest, finally revealing inflammatory pseudotumor.
The first specimen had excessive crushing artifacts. Microscopically, small round cells which stained blue were identified. Small round inflammatory cells seen clumped or grouped together can make them seem neoplastic. Because small round cells are non-specific, special stains are needed ( Table 2) . Unfortunately, the excessive crushing of the specimen made this virtually impossible to accomplish.
The next biopsy again showed small round blue cells in clusters suggesting a neoplasm. Special staining negative for Chromogranin and LCA but positive for NSE supported a neuroendocrine tumor such as olfactory neuroblastoma but was not confirmatory. NSE is not a specific marker and needs chromogranin to stain positive for the diagnosis to be consistent with olfactory neuroblastoma. The pathologist could not commit to a diagnosis and suggested another biopsy, which gave a clue to the inflammatory nature of this disease. Microscopically, inflammatory cells such as lymphocytes, plasma cells and histiocytes were seen. However, the specimen was signed out only as acute and chronic inflammation because such cells are non-specific findings in any inflammatory process. But these cells also could very well be present at the surface of any malignant tumor. Tumor debulking provided a clearer pattern of cellular distribution with inflammatory cells present throughout the whole specimen. The pathological picture of dense fibrous tissue with aggregates of lymphocytes, plasma cells and histiocytes is the hallmark of inflammatory pseudotumor, but this basis is non-specific 3 . It is precisely the non-specific nature of the lesion which makes diagnosis difficult and limits the diagnostic yield of small biopsies. It was not that the specimens submitted were inadequate; the non-specific nature of the lesion could only be confirmed by getting the specimen in toto -a practice not commonly employed when dealing with a suspicious malignant-looking mass in an inaccessible area in the head and neck. Inflammatory pseudotumor (IPT) is a rarely occurring lesion with no identifiable local or systemic causes. The lesions mimic expansive, invasive, malignant tumors both clinically and radiologically, hence the term "pseudotumor". IPT most commonly involves the lung and orbit. It has been reported in nearly every site in the body but is most common in the orbit and rare in the sinuses 5 . In our case, we believe that the mass was primarily an orbital lesion which extended into the maxillary sinus and not the other way around.
The behavior of IPT can be quite unpredictable 3 . Some resolve spontaneously and others respond to corticosteroids. In some cases, tapering steroid doses cause lesions to recur. For lesions not responding to steroids, subtotal excision with or without radiotherapy may be required 3 .
IPT is an idiopathic inflammatory lesion although various stimuli may cause it to develop such as unrecognized organisms, minor trauma, smoking, and chronic irritation by cocaine abuse 1 . The characteristic feature of IPT lies not in the inciting agent but in its response to a trigger agent. According to Williams et al 4 , the underlying mechanism in the development of IPT is localized derangement in the immune response after a particular initial insult. Other authors relate IPT to production of mediators of inflammation which stimulate proliferation of fibroblasts, extravasation of neutrophils and activation of procoagulant activity of the vascular endothelium. It also induces production of acute phase reactants, proteolysis and neurologic disturbances 1 .
The most frequent symptom is swelling and pain although other local symptoms depend on the site of involvement.
A very similar case was seen in Japan by Takashi Nakagawa et.al. 2 where a 63 year old male presented with left eye lacrimation and exopthalmos. CT and MRI studies strongly suggested a malignant tumor of the maxillary sinus. A biopsy was also done which revealed IPT. Like our case, this patient did not respond to corticosteroids. Because total excision of the mass could not be achieved, debulking was done and there have been no observed further changes in the size of the mass several months after.
Another study done in New York by PM Som et al 6 discussed 6 cases of IPT of the maxillary sinus. This study showed that IPT of the maxillary Heathcote and Safneck 3 reported a case of a 5-year-old boy who presented with eyelid swelling and was admitted with a diagnosis of orbital cellulitis. A CT scan performed the day after admission revealed a mass in the lateral orbit. Rather than the presumptive diagnosis of rhabdomyosarcoma, a biopsy revealed sclerosing IPT.
Among the different ancillary procedures, CT scan has proven to be of value in defining the extension of IPT and its response to treatment. In the orbit, the most frequent radiologic characteristics are retrobulbar fatty infiltration, proptosis, EOM enlargement and apical fat edema. In extraorbital locations in the head and neck, a mass lesion with sharp enhancement is consistently reported. IPT has an aggressive appearance and there is usually bone involvement like erosion, remodeling or sclerosis.
The unifying histologic feature of IPT is the highly variable mixture of bland-looking spindle cells and inflammatory cells 1 . The liberation of cytotoxic proteins from eosinophil granules may promote fibrosis and may also contribute to the degeneration of the extraocular muscles in IPT.
Histopathologic diagnosis of IPT is difficult and differential diagnosis from malignant tumors is often a concern for otolaryngologists and pathologists. Hence, coordination between these 2 specialties facilitates handling such difficult cases as this. The role of the ENT specialist in correlating history, physical examination, ancillary procedures and histopathology in spite of disparities cannot be overemphasized. In spite of an initial malignant biopsy result, the combination of clinical signs and symptoms and radiologic findings of an infiltrative mass lesion, should not discount the possibility of a benign entity such as IPT for which treatment is conservative, and unnecessary and potentially mutilating surgery can be avoided. 
